Rutaretin1′-(6″-sinapoylglucoside): promising inhibitor of COVID 19 m^pro catalytic dyad from the leaves of Pittosporum dasycaulon miq (Pittosporaceae)

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindah, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science (New York, NY), 300(5626), 1763–1767. 2003). https://doi.org/10.1126/science.1085658
   Google Scholar
• Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004). Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry, 43(17), 4906–4912. https://doi.org/10.1021/bi0361766
   PubMed Web of Science ®Google Scholar
• Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015). The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Research, 115(December), 21–38. https://doi.org/10.1016/j.antiviral.2014.12.015
   PubMedGoogle Scholar
• Barot, K. P., Jain, S. V., Kremer, L., Singh, S., & Ghate, M. D. (2015). Recent advances and therapeutic journey of coumarins: Current status and perspectives. Medicinal Chemistry Research, 24(7), 2771–2798. https://doi.org/10.1007/s00044-015-1350-8
   Web of Science ®Google Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Bluhm, W. F., Philip, E., Marvin, J., Weissig, H., & John, D. (2002). Research papers The Protein Data Bank research papers. Acta Crystallographica, D58, 899–907.
   PubMed Web of Science ®Google Scholar
• Bhal, S. K., Kassam, K., Peirson, I. G., & Pearl, G. M. (2007). The rule of five revisited: Applying log D in place of log P in drug-likeness filters. Molecular Pharmaceutics, 4(4), 556–560. https://doi.org/10.1021/mp0700209
   PubMed Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. Journal of Chemical Physics, 126(1) https://doi.org/10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Campling, B. G., Pym, J., Baker, H. M., Cole, S. P. C., & Lam, Y. M. (1991). Chemosensitivity testing of small cell lung cancer using the mtt assay. British Journal of Cancer, 63(1), 75–83. https://doi.org/10.1038/bjc.1991.16
   PubMed Web of Science ®Google Scholar
• Chan, J. F., Kok, K., Zhu, Z., Chu, H., Kai-Wang, K., Yuan, S., & Yuen, K. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections, 9(1), 221–236. https://doi.org/10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Chandel, V., Raj, S., & Rathi, B., K. D. (2020). Approved antiviral compounds and active phytochemicals through molecular docking. A Drug Repurposing Approach, 7(3), 1–10. https://doi.org/10.20944/preprints202003.0349.v1
   Google Scholar
• Cunha, C. B., & Opal, S. M. (2014). Middle east respiratory syndrome (MERS): A new zoonotic viral pneumonia. Virulence, 5(6), 650–654. https://doi.org/10.4161/viru.32077
   PubMed Web of Science ®Google Scholar
• De Oliveira Costa, A. C., Fernandes, J. M., Da Silva Negreiros Neto, T., Mendonça, J. N., Tomaz, J. C., Lopes, N. P., Soares, L. A. L., & Zucolotto, S. M. (2015). Quantification of chemical marker of Kalanchoe brasiliensis (crassulaceae) leaves by HPLC-DAD. Journal of Liquid Chromatography & Related Technologies, 38(7), 795–800. https://doi.org/10.1080/10826076.2014.971370
   Web of Science ®Google Scholar
• Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., & B.-A, D. (2020). Crossm. Clinical Microbilogy Reviews, 33(4), 1–48.
   Google Scholar
• Dong, S., Sun, J., Mao, Z., Wang, L., Lu, Y. L., & Li, J. (2020). A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV). Journal of Medical Virology, 92(9), 1542–1548. https://doi.org/10.1002/jmv.25768
   PubMed Web of Science ®Google Scholar
• Eby, T. L., Arteaga, A. A., & Spankovich, C. (2020). Otologic and audiologic considerations for COVID-19. Otolaryngology-Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 163(1), 110–111. https://doi.org/10.1177/0194599820928989
   PubMed Web of Science ®Google Scholar
• Fielding, B. C., da Silva Maia Bezerra Filho, C., Ismail, N. S. M., & Sousa, D. P. d. (2020). Alkaloids: Therapeutic potential against human coronaviruses. Molecules (Basel, Switzerland), 25(23), 1–17. https://doi.org/10.3390/molecules25235496
   Google Scholar
• Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi-Fainaro, R. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology, 15(8), 630–645. https://doi.org/10.1038/s41565-020-0732-3
   PubMed Web of Science ®Google Scholar
• Frediansyah, A., Tiwari, R., Sharun, K., Dhama, K., & Harapan, H. (2021). Antivirals for COVID-19: A critical review. Clinical Epidemiology and Global Health, 9(July), 90–98. https://doi.org/10.1016/j.cegh.2020.07.006
   PubMedGoogle Scholar
• Ghanbari, B. (2020). On forecasting the spread of the COVID-19 in Iran: The second wave. Chaos, Solitons, and Fractals, 140(2020), 110176–110178. https://doi.org/10.1016/j.chaos.2020.110176
   PubMedGoogle Scholar
• Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., & Tang, Y. (2019). ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm, 10(1), 148–157. https://doi.org/10.1039/c8md00472b
   PubMed Web of Science ®Google Scholar
• Guastalegname, M., & Vallone, A. (2020). Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID19) treatment? Clinical Infectious Diseases, 71(15), 888–889. https://doi.org/10.1093/cid/ciaa320
   PubMed Web of Science ®Google Scholar
• Hajighasemi, F., & Mirshafiey, A. (2010). Propranolol effect on proliferation and vascular endothelial growth factor secretion in human immunocompetent cells. Journal of Clinical Immunology and Immunopathology Research, 2(2), 22–27.
   Google Scholar
• Hoda, S., Gupta, L., Agarwal, H., Raj, G., Vermani, M., & Vijayaraghavan, P. (2019). Inhibition of Aspergillus fumigatus biofilm and cytotoxicity study of natural compound Cis-9-Hexadecenal. Journal of Pure and Applied Microbiology, 13(2), 1207–1216. https://doi.org/10.22207/JPAM.13.2.61
   Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, H., Kim, S., Shin, D. H., & Kim, M. S. (2019). Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chemical Biology & Drug Design, 94(6), 2023–2030. https://doi.org/10.1111/cbdd.13604
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, S., Shin, D. H., & Kim, M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 145–151. https://doi.org/10.1080/14756366.2019.1690480
   PubMed Web of Science ®Google Scholar
• Joshi, T., Joshi, T., Sharma, P., Mathpal, S., Pundir, H., Bhatt, V., & Chandra, S. (2020). In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. European Review for Medical and Pharmacological Sciences, 24(8), 4529–4536.https://doi.org/10.26355/eurrev_202004_21036
   PubMed Web of Science ®Google Scholar
• Kalanchoe, F. (1994). Patuletin acetylrhamnosides. Journal of Natural Products, 57(11), 1503–1510.
   PubMedGoogle Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2015). PubChem substance and compound databases. Nuclic Acid Reasearch, 1, 1–12. https://doi.org/10.1093/nar/gkv951
   Google Scholar
• Kitazato, K., Wang, Y., & Kobayashi, N. (2007). Viral infectious disease and natural products with antiviral activity. Drug Discoveries & Therapeutics, 1(1), 14–22. http://www.ncbi.nlm.nih.gov/pubmed/22504360
   PubMedGoogle Scholar
• Kumbhar, S. T., Patil, S. P., & Une, H. D. (2018). Phytochemical analysis of Canna indica L. roots and rhizomes extract. Biochemistry and Biophysics Reports, 16(September), 50–55. https://doi.org/10.1016/j.bbrep.2018.09.002
   PubMedGoogle Scholar
• Lawso, D. R., Green, T. P., Haynes, L. R. W., & Raymond Miller, A. (1997). Nuclear magnetic resonance spectroscopy and mass spectrometry of solanidine, leptinidine, and acetylleptinidine. Steroidal alkaloids from Solanum chacoense bitter. Journal of Agricultural and Food Chemistry, 45(10), 4122–4126. https://doi.org/10.1021/jf9702914
   Web of Science ®Google Scholar
• Lee, P. I., & Hsueh, P. R. (2020). Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. Journal of Microbiology, Immunology, and Infection = Wei Mian yu Gan Ran za Zhi, 53(3), 365–367. https://doi.org/10.1016/j.jmii.2020.02.001
   PubMedGoogle Scholar
• Lindahl, E., Bjelkmar, P., Larsson, P., Cuendet, M. A., & Hess, B. (2010). Implementation of the charmm force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. Journal of Chemical Theory and Computation, 6(2), 459–466. https://doi.org/10.1021/ct900549r
   PubMed Web of Science ®Google Scholar
• Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery, 6(1), 16–19. https://doi.org/10.1038/s41421-020-0156-0
   PubMed Web of Science ®Google Scholar
• Liu, X., Zhang, B., Jin, Z., & Yang, H., R. Z. (2020). The crystal structure of COVID-19 main protease in complex with an inhibitor N3. Protein DataBank. https://doi.org/10.2210/pdb6lu7/pdb
   Google Scholar
• Liu, X., & Wang, X. J. (2020). Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. Journal of Genetics and Genomics = Yi Chuan Xue Bao, 47(2), 119–121. https://doi.org/10.1016/j.jgg.2020.02.001
   PubMed Web of Science ®Google Scholar
• Malabadi, R. B. (2021). Role of herbal medicine for controlling coronavirus (SARS-CoV-2) disease (COVID-19). International Journal of Research and Scientific Innovation (IJRSI), 8(2), 135–165.
   Google Scholar
• Mirza, M. U., & Froeyen, M. (2020). Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. Journal of Pharmaceutical Analysis, 10(4), 320–328. https://doi.org/10.1016/j.jpha.2020.04.008
   PubMed Web of Science ®Google Scholar
• Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. The Lancet. Infectious Diseases, 14(11), 1090–1095. https://doi.org/10.1016/S1473-3099(14)70920-X
   PubMed Web of Science ®Google Scholar
• Owa, A. B., & Owa, O. T. (2020). Lopinavir/ritonavir use in Covid-19 infection: Is it completely non-beneficial? Journal of Microbiology, Immunology, and Infection = Wei Mian yu Gan Ran za Zhi, 53(5), 674–675. https://doi.org/10.1016/j.jmii.2020.05.014
   PubMedGoogle Scholar
• Pathak, K., & Raghuvanshi, S. (2015). Oral bioavailability: Issues and solutions via nanoformulations. Clinical Pharmacokinetics, 54(4), 325–357. https://doi.org/10.1007/s40262-015-0242-x
   PubMed Web of Science ®Google Scholar
• Pathak, N., Chen, Y. T., Hsu, Y. C., Hsu, N. Y., Kuo, C. J., Tsai, H. P., Kang, J. J., Huang, C. H., Chang, S. Y., Chang, Y. H., Liang, P. H., & Yang, J. M. (2021). Uncovering flexible active site conformations of SARS-CoV-2 3CL proteases through protease pharmacophore clusters and COVID-19 drug repurposing. ACS Nano, 15(1), 857–872. https://doi.org/10.1021/acsnano.0c07383
   PubMed Web of Science ®Google Scholar
• Peretto, G., Sala, S., & Caforio, A. L. P. (2020). Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement. European Heart Journal, 41(22), 2124–2125. https://doi.org/10.1093/eurheartj/ehaa396
   PubMed Web of Science ®Google Scholar
• Puttaswamy, H., Gowtham, H. G., Ojha, M. D., Yadav, A., Choudhir, G., Raguraman, V., Kongkham, B., Selvaraju, K., Shareef, S., Gehlot, P., Ahamed, F., & Chauhan, L. (2020). In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis. Scientific Reports, 10(1), 20524–20584. https://doi.org/10.1038/s41598-020-77602-0
   PubMed Web of Science ®Google Scholar
• Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252(April), 117652. https://doi.org/10.1016/j.lfs.2020.117652
   PubMedGoogle Scholar
• Sheng, Y. J., Yin, Y. W., Ma, Y. Q., & Ding, H. M. (2021). Improving the performance of MM/PBSA in protein-protein interactions via the screening electrostatic energy. Journal of Chemical Information and Modeling, 61(5), 2454–2462. https://doi.org/10.1021/acs.jcim.1c00410
   PubMed Web of Science ®Google Scholar
• Silveira, D., Prieto-Garcia, J. M., Boylan, F., Estrada, O., Fonseca-Bazzo, Y. M., Jamal, C. M., Magalhães, P. O., Pereira, E. O., Tomczyk, M., & Heinrich, M. (2020). COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Frontiers in Pharmacology, 11, 581840. https://doi.org/10.3389/fphar.2020.581840
   PubMed Web of Science ®Google Scholar
• Sjögren, E., Westergren, J., Grant, I., Hanisch, G., Lindfors, L., Lennernäs, H., Abrahamsson, B., & Tannergren, C. (2013). In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim. European Journal of Pharmaceutical Sciences, 49(4), 679–698. https://doi.org/10.1016/j.ejps.2013.05.019
   PubMed Web of Science ®Google Scholar
• Steenkamp, V., & Gouws, M. C. (2006). Cytotoxicity of six South African medicinal plant extracts used in the treatment of cancer. South African Journal of Botany, 72(4), 630–633. https://doi.org/10.1016/j.sajb.2006.02.004
   Web of Science ®Google Scholar
• Thawabteh, A., Juma, S., Bader, M., Karaman, D., Scrano, L., Bufo, S. A., & Karaman, R. (2019). The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins, 11(11), 1–28. https://doi.org/10.3390/toxins11110656
   Google Scholar
• Thorne, H. V., Clarke, G. F., & Skuce, R. (1985). The inactivation of herpes simplex virus by some Solanaceae glycoalkaloids. Antiviral Research, 5(6), 335–343. https://doi.org/10.1016/0166-3542(85)90003-8
   PubMed Web of Science ®Google Scholar
• Topçu, G., Şenol, H., Alim Toraman, G. Ö., & Altan, V. M. (2020). Natural alkaloids as potential anti-coronavirus compounds. Bezmialem Science, 8(3), 131–139. https://doi.org/10.14235/bas.galenos.2020.5035
   Google Scholar
• Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6(March), 22612–22677. https://doi.org/10.1038/srep22677
   PubMedGoogle Scholar
• Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/10.1128/JVI.02114-07
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Yousefi, H., Mashouri, L., Okpechi, S. C., Alahari, N., & Alahari, S. K. (2021). Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Biochemical Pharmacology, 183(183), 114294–114296. https://doi.org/10.1016/j.bcp.2020.114296
   Google Scholar
• Yuce, M., Cicek, E., Inan, T., Dag, A. B., Kurkcuoglu, O., & Sungur, F. A. (2021). Repurposing of FDA‐approved drugs against active site and potential allosteric drug binding sites of COVID ‐19 main protease. Proteins: Structure, Function, and Bioinformatics, 89(6), 1–17. https://doi.org/10.1002/prot.26164
   Google Scholar